Medical Advocates
Elvitegravir/TenofovirDF/Emtricitabine/Cobicistat
(Stribild)
 
Main Page

New and Noteworthy
Journal Abstracts, Papers, and Commentaries
Conference Reports, Abstracts, and Posters
Cobicistat
 FDA Approval



 
ARVs Main Page Main New/Noteworthy Home Page      
Last Update:  February 27, 2018
Documents identified with this icon are in Portable Document Format (PDF) and require the Adobe Acrobat Reader
New and Noteworthy
 
November 2017
 
 
FDA Approval
     
FDA approves new once a day pill for HIV

ARVs Main Page Main New/Noteworthy Home Page      

 Elvitegravir/Tenofovir DF/Emtricitabine/Cobicistat Main Page